These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


175 related items for PubMed ID: 2678298

  • 1. Gd DTPA: a review of clinical indications in central nervous system magnetic resonance imaging.
    Runge VM, Carollo BR, Wolf CR, Nelson KL, Gelblum DY.
    Radiographics; 1989 Sep; 9(5):929-58. PubMed ID: 2678298
    [Abstract] [Full Text] [Related]

  • 2. [The enhancement effects of Gd-DTPA for cerebrospinal lesions-- comparison with conventional T2-weighted images].
    Mano I, Yoshida H, Kono T, Tsuchida T, Terao H, Iio M.
    Rinsho Hoshasen; 1987 Dec; 32(13):1547-53. PubMed ID: 3448287
    [No Abstract] [Full Text] [Related]

  • 3. Gd DTPA. Clinical efficacy.
    Runge VM, Schaible TF, Goldstein HA, Wood ML, Haughton VM, Maravilla KR, Weinstein MA, Price AC, Wolpert SM, Kaufman D.
    Radiographics; 1988 Jan; 8(1):147-59. PubMed ID: 3353531
    [Abstract] [Full Text] [Related]

  • 4. [Gadolinium DTPA in magnetic resonance. Clinical experience in intracranial pathology].
    Bradac GB, Riva A, Berger T, Stura G, Duca S.
    Radiol Med; 1988 Jan; 76(1-2):33-7. PubMed ID: 3399707
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. MR contrast enhancement of intracranial lesions with Gd-DTPA.
    Hesselink JR, Press GA.
    Radiol Clin North Am; 1988 Jul; 26(4):873-87. PubMed ID: 3289078
    [Abstract] [Full Text] [Related]

  • 7. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
    Clément O, Mühler A, Vexler V, Berthezène Y, Brasch RC.
    Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
    [Abstract] [Full Text] [Related]

  • 8. Contrast-enhanced magnetic resonance imaging of the abdomen and pelvis.
    Hamm B, Laniado M, Saini S.
    Magn Reson Q; 1990 Apr; 6(2):108-35. PubMed ID: 2202422
    [Abstract] [Full Text] [Related]

  • 9. Gd-DTPA-enhanced MR imaging of spinal tumors.
    Parizel PM, Balériaux D, Rodesch G, Segebarth C, Lalmand B, Christophe C, Lemort M, Haesendonck P, Niendorf HP, Flament-Durand J.
    AJR Am J Roentgenol; 1989 May; 152(5):1087-96. PubMed ID: 2705343
    [Abstract] [Full Text] [Related]

  • 10. [Efficacy of gadobenate dimeglumine vs gadopentetate dimeglumine in contrast- enhanced magnetic resonance imaging for diagnosis of solitary brain metastases].
    Wang QJ, Wang Y, Xu X, Xiao H, Ma L.
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):1968-73. PubMed ID: 22200693
    [Abstract] [Full Text] [Related]

  • 11. [Contrast-enhanced MR imaging using double doses of gadolinium-DTPA in evaluating brain and spinal diseases].
    Matsumoto S, Hasuo K, Uchino A, Matsuura Y, Gibo M, Fukui M, Masuda K.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1993 May 25; 53(5):503-10. PubMed ID: 8327315
    [Abstract] [Full Text] [Related]

  • 12. [The contrast enhancement of brain and spinal cord tumors using Gd-DTPA in magnetic resonance tomography with an extra-low magnetic-field intensity].
    Kornienko VN, Pronin IN, Turkin AM, Fadeeva LM.
    Zh Vopr Neirokhir Im N N Burdenko; 1993 May 25; (4):13-7. PubMed ID: 8296501
    [Abstract] [Full Text] [Related]

  • 13. Indications for gadolinium-DTPA in magnetic resonance evaluation of extracranial head and neck mass lesions: review of experience with 27 patients examined with a 2 tesla imager.
    Chisin R, Gomori JM, Elidan J.
    Isr J Med Sci; 1992 May 25; 28(3-4):268-76. PubMed ID: 1592599
    [Abstract] [Full Text] [Related]

  • 14. [Use of Omniscan (gadodiamide) in magnetic resonance studies of the central nervous system (results of a multicenter study)].
    Sinitsyn VE, Kornienko VN, Nikitin VG, Pronin IN, Ternovoĭ SK, Tiutin LA, Iakobson MG.
    Vestn Rentgenol Radiol; 1995 May 25; (4):5-11. PubMed ID: 8571538
    [Abstract] [Full Text] [Related]

  • 15. [Acoustic neurinomas. Magnetic resonance tomography using the contrast medium Gd-DTPA].
    Pronin IN, Kornienko VN.
    Zh Vopr Neirokhir Im N N Burdenko; 1995 May 25; (2):16-7. PubMed ID: 7625134
    [Abstract] [Full Text] [Related]

  • 16. Gadodiamide injection: nonionic gadolinium chelate for MR imaging of the brain and spine--phase II-III clinical trial.
    Greco A, McNamara MT, Lanthiez P, Quay SC, Michelozzi G.
    Radiology; 1990 Aug 25; 176(2):451-6. PubMed ID: 2195593
    [Abstract] [Full Text] [Related]

  • 17. Application of Gd-DTPA in diseases of the central nervous system.
    Shen TZ, Mei H, Huang XL, Chen XR.
    Chin Med J (Engl); 1991 Apr 25; 104(4):313-20. PubMed ID: 2065550
    [Abstract] [Full Text] [Related]

  • 18. [Nuclear magnetic resonance tomography using gadolinium-DTPA in the diagnosis of spinal lesions].
    Fenzl G, Heywang SH, Vogl T.
    Rofo; 1988 Apr 25; 148(4):415-8. PubMed ID: 2834789
    [Abstract] [Full Text] [Related]

  • 19. [Gadolinium-DTPA in the study of intracranial tumors in the adult].
    Grégoire N, Momose T, Rumeau C, Perot S, Girard N, Lavanga A, Salamon G.
    Rev Neurol (Paris); 1990 Apr 25; 146(2):133-43. PubMed ID: 2320818
    [Abstract] [Full Text] [Related]

  • 20. [MRI of the nasopharynx with Gd-DTPA: its value and differential diagnostic criteria].
    Vogl T, Dresel S, Schedel H, Markl A, Grevers G, Stelzer S, Lissner J.
    Rofo; 1989 May 25; 150(5):516-22. PubMed ID: 2541475
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.